September 2026 Memos
Main content blocks
Skip SeptemberSeptember
The Fraud Downdraft and Physician Recruitment in Hospice
09/28/2026 • 5 Minute Read
Executive Summary
Fraud enforcement activity in home health and hospice may be creating consequences beyond the organizations directly involved. As physicians evaluate hospice medical director opportunities, concerns about Medicare enrollment exposure, professional reputation, and practice disruption may influence recruitment and retention decisions. CMS affiliation authorities make compliance, transparency, and organizational governance increasingly important factors in a physician's decision to accept or maintain a leadership role. Hospice organizations should be prepared for more rigorous physician due diligence and should demonstrate how they support informed medical oversight, compliance, and responsible leadership.
CMS affiliation actions may affect physicians beyond the hospice role.
Physicians may become more selective about leadership opportunities.
Physicians may closely evaluate compliance and operational history.
Transparency and oversight support physician confidence.
The Potential Recruitment Downdraft
Compliance is becoming part of the conversation about whether a physician can confidently place a career and reputation alongside a hospice organization.
The fraudulent activity uncovered in home health and hospice has consequences that reach beyond the organizations involved. Another possible part of the industry's continuing “downdraft” may be felt when a hospice attempts to recruit or retain a medical director. A physician considering that responsibility may reasonably ask what could happen to a practice, Medicare enrollment, and professional reputation if an affiliated organization is not operating appropriately.
In his article, “CMS’s Affiliation Rule: Medicare Enrollment Risk for Hospice Medical Directors,” Scott S. Driggs highlights physician enrollment exposure associated with affiliation-related enforcement. For hospice leaders, this raises a practical concern: will qualified physicians become more reluctant to accept these positions, even with responsible providers?
Understanding Physician Enrollment Exposure
Under 42 CFR § 424.535, CMS may revoke enrollment for an affiliation it determines poses an undue risk and may extend revocation to a physician's other Medicare enrollments. Reenrollment bars generally range from one to ten years, with longer periods possible in specified circumstances, including a second revocation. If a physician is placed on CMS's preclusion list, Medicare Advantage payments for the physician's services and Part D coverage of the physician's prescriptions may also be affected.
These consequences can disrupt an established practice, patient relationships, and income even when the physician retains a state medical license. Importantly, enrollment consequences and state licensure actions are separate matters. Affiliation with a noncompliant provider does not automatically result in loss of a medical license, which would require separate action by the appropriate state licensing authority. Even so, Medicare enrollment consequences alone may significantly affect a physician's livelihood.
Why Recruitment May Become More Challenging
Legitimate hospice organizations may face a more difficult recruitment environment as physicians evaluate these risks. Physicians considering a medical director position may wish to review ownership structures, survey and audit history, billing concerns, organizational leadership, and leadership's response to identified problems before accepting a role.
Physicians may also seek legal review of proposed contracts, evaluate insurance coverage, request access to organizational records, and review authority to escalate concerns. Organizations should welcome this due diligence and be prepared to demonstrate how they support informed medical oversight and responsible governance.
5 Recommendations for Hospice Organizations
- Make physician due diligence part of the recruitment process by providing meaningful access to ownership information, survey findings, audit results, corrective actions, enrollment history, and other relevant compliance information.
- Define responsibilities, access rights, escalation authority, and notification requirements in written agreements, and maintain documentation that demonstrates meaningful physician oversight and participation.
- Use available operational data including length of stay, live discharges, visit patterns, denials, and other indicators to support ongoing discussions with medical directors and document resulting actions and conclusions.
- Provide ongoing education regarding eligibility requirements, documentation expectations, escalation responsibilities, Medicare enrollment rules, preclusion concepts, and distinctions between enrollment actions and state licensure actions.
- Respond promptly to payment suspensions, enrollment notices, billing findings, credential misuse concerns, and other adverse actions while preserving records, identifying appeal deadlines, and obtaining qualified enrollment counsel when appropriate.
Key Operational Considerations
Organizations should conduct ongoing reviews rather than limiting due diligence to the recruitment stage. Ownership changes, leadership transitions, survey outcomes, and compliance events may warrant reassessment of organizational risk and disclosure obligations.
Documentation remains particularly important. Records supporting physician review of eligibility determinations, certifications, unresolved clinical concerns, corrective actions, and operational oversight can help demonstrate meaningful participation and informed decision-making. Technology and business intelligence tools may assist organizations in identifying trends and focusing reviews, but they do not replace clinical judgment or determine legal responsibility.
When adverse events occur, physicians and organizations should carefully preserve contracts, service records, correspondence, clinical reviews, and other supporting documentation. Organizations should also establish plans for physician coverage and patient continuity if participation becomes disrupted.
The Leadership Challenge Ahead
The downdraft from fraud enforcement may reach physicians deciding whether to join hospice organizations. Leaders should expect more questions, closer scrutiny, and higher expectations regarding governance, oversight, and compliance practices. Earning physician confidence increasingly depends on demonstrating how the organization operates, how concerns are addressed, and how sound clinical judgment is supported throughout the organization.
Source Credit
This Maxim Memo offers Arlene Maxim's commentary on the potential physician recruitment and due diligence implications of fraud enforcement in home health and hospice. Scott S. Driggs's article, “CMS's Affiliation Rule: Medicare Enrollment Risk for Hospice Medical Directors,” published by Snell & Wilmer on September 16, 2026, informed the discussion of physician enrollment risk. Credit for that legal analysis belongs to the author and firm. The recruitment implications discussed here are the author's assessment. 【1-8c9081】
Original Source: Read the original article by Scott S. Driggs (September 16, 2026) . 【1-8c9081】
Related Maxim Memo: “The Downdraft Is Getting Stronger: Home Health and Hospice Are Back in the Crosshairs” Arlene Maxim, RN, HCS-C, September 14, 2026. 【1-8c9081】
Additional Reference: CMS announcement of affiliation enforcement authority (September 5, 2019) . 【1-8c9081】
💬 Discussion Question
If a prospective medical director requested evidence of your organization's compliance culture, enrollment oversight processes, and response to prior regulatory concerns, what information would you be prepared to provide today?
Medicare is Using AI to Review Care: Is Your Documentation Ready?
09/21/2026 • 8 Minute Read
Executive Summary
CMS's WISeR Model is not currently a home health or hospice prior authorization program, but it provides valuable insight into the direction of Medicare program integrity efforts. As CMS expands its use of artificial intelligence, machine learning, analytics, and technology-assisted review processes, healthcare organizations should expect increasing attention on documentation consistency, measurable outcomes, utilization patterns, and data integrity. Agencies already generate extensive electronic footprints through claims, assessments, functional scores, certifications, quality measures, and clinical narratives. The organizations best prepared for future oversight will not necessarily create the most documentation. They will create documentation that is accurate, consistent, measurable, defensible, and able to tell one clear clinical story from start to finish.
CMS is increasingly using technology to support program integrity efforts.
Every diagnosis, assessment, claim, and clinical note contributes to Medicare's view of your agency.
Technology can identify conflicting documentation faster than manual review.
Training should turn identified risks into measurable improvement.
What WISeR Reveals About Medicare's Direction
The biggest story is not prior authorization. The biggest story is Medicare's increasing ability to use technology and data to identify records, providers, services, documentation, and utilization patterns that may warrant closer review.
If you still believe Medicare review is simply a matter of a human auditor opening a chart and reading your documentation from beginning to end, it may be time to rethink that belief.
Newly released records concerning CMS's Wasteful and Inappropriate Service Reduction (WISeR) Model brought renewed attention to Medicare's use of technology in prior authorization. Reports based on documents released through litigation described early implementation challenges that included delayed decisions, technology issues, and provider frustration.
CMS describes WISeR as a model that uses enhanced technologies, including artificial intelligence (AI) and machine learning (ML), together with human clinical review to determine whether selected services meet existing Medicare requirements.
It is important to understand exactly what WISeR is and what it is not. WISeR is not currently a home health or hospice prior authorization program. It applies to selected items and services under Original Medicare in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.
CMS has stated that WISeR does not change Medicare coverage or payment policy and that recommendations for non-payment are determined by appropriately licensed clinicians. Human review remains an essential component of the decision-making process.
Nevertheless, home health and hospice leaders should pay close attention to what CMS is testing. The implications extend well beyond prior authorization. Medicare's ability to identify unusual patterns, documentation inconsistencies, utilization trends, and potential areas of concern continues to evolve as technology capabilities improve.
Your Agency's Electronic Footprint Matters More Than Ever
Home health and hospice organizations already create an enormous electronic footprint. Diagnoses, claims, OASIS data, functional scores, visit patterns, hospitalizations, length of stay, certification information, quality measures, and clinical narratives all contribute to the story an agency tells Medicare.
Every data element contributes to a larger narrative. When those data elements support one another, they strengthen the clinical story. When they conflict, they create questions.
Consider several examples:
- If a diagnosis says one thing, an assessment says another, and the clinical narrative tells a third story, that inconsistency matters.
- If a hospice record repeatedly states that a patient is declining while measurable findings remain unchanged, the record deserves closer review.
- If a home health record supports homebound status in one section while another section contains unexplained information that appears inconsistent with that status, additional scrutiny may follow.
Documentation consistency is no longer simply a quality improvement objective. In an environment increasingly influenced by analytics and artificial intelligence, consistency is becoming a compliance requirement.
Technology Can Find Patterns Faster Than People
Technology can identify patterns much faster than a person reviewing one chart at a time. That does not mean technology replaces clinical judgment. CMS specifically requires clinician involvement in WISeR non-payment recommendations.
What technology can do is identify the record, provider, service, or utilization pattern that deserves additional review. Analytics can detect trends across hundreds or thousands of records in a fraction of the time required for traditional manual review.
The lesson for healthcare leaders is simple: agencies need to become as sophisticated about reviewing their own data as Medicare is becoming about reviewing healthcare data.
Using Technology to Move From Detection to Correction
For organizations using Axxess, this same concept can be applied internally. Leaders can use Business Intelligence to see patterns, Axxess intelligence® to surface information and clinical insights more efficiently, and Training and Certification+ to address staff knowledge or workflow gaps revealed by the data.
Technology delivers its greatest value when it helps leaders move beyond simply finding a problem and allows them to correct it. Identifying risks is only the first step. Sustainable improvement comes from understanding root causes and implementing targeted corrective action.
5 Tips for Success
1. Make Sure the Entire Record Tells ONE Story
The diagnosis, assessment, plan of care, orders, visit notes, functional scores, certification documentation, and claims data should support one another. Contradiction in documentation creates questions, and questions can lead to deeper review.
2. Audit Patterns, Not Just Individual Charts
Do not limit quality assurance activities to whether a single clinician completed a note correctly. Look across the entire organization. Review utilization, visit frequency, diagnoses, functional scores, hospitalizations, length of stay, recertifications, and other outliers.
Sometimes the greatest compliance risks become visible only when leaders view all data together. This is where Axxess Business Intelligence can be especially helpful. Business Intelligence provides leaders with a way to visualize key clinical, operational, financial, and quality information so they can identify trends and outliers and intervene before an outside reviewer identifies the same pattern.
3. Make Every Number Defensible
PPS, FAST, OASIS responses, functional scores, pain scales, LMAC measurements, weight, and other measurable findings should be supported by the clinical record. If the number and the narrative do not agree, determine why before an outside reviewer does.
4. Use Technology to Review Your Agency Before Someone Else Does
Axxess Business Intelligence can help leadership visualize trends and key performance information, while Axxess intelligence® brings AI-powered capabilities into everyday clinical, operational, and financial workflows.
Features such as Ask Axxess and Clinical Insights can make important information and clinical trends easier to find so teams can identify needs and act faster. However, these tools should support, not replace, clinical judgment, compliance oversight, and appropriate human review.
5. Teach Clinicians WHY Documentation Matters
"Document more" is not the answer. Better and more transparent documentation is. Clinicians need to understand how their documentation supports medical necessity, eligibility, the plan of care, and the patient's clinical story.
Point-of-care documentation is always best. Axxess Training and Certification+ can help agencies turn identified weaknesses into targeted education through role-based clinical, operational, financial, and regulatory learning.
When BI or AI identifies a recurring documentation or workflow issue, leadership can use education and certification to close the loop: identify the risk, educate the team, reassess performance, and determine whether improvement occurred.
Every sentence documented must have a purpose.
My Takeaway
WISeR may not be reviewing your home health or hospice claim today. But the technology behind this type of Medicare oversight should tell us something about the direction of program integrity.
Data can identify the outlier. AI can identify the inconsistency. Analytics can identify the pattern. Then a human reviewer can open the record.
The agencies that prepare for that environment will not necessarily be the ones producing the most documentation. They will be the ones producing documentation that is accurate, consistent, measurable, and tells a clear clinical story.
Don't wait for Medicare's technology to find your inconsistencies. Find them first.
5 Recommendations for Home Health and Hospice Organizations
- Evaluate documentation consistency across diagnoses, assessments, plans of care, visit notes, certifications, and claims to ensure every part of the record supports the same clinical story.
- Expand quality assurance efforts beyond individual chart review and actively monitor organization-wide patterns involving utilization, hospitalizations, lengths of stay, recertifications, and functional outcomes.
- Validate that all measurable findings and assessment scores are supported by objective clinical documentation and narrative descriptions.
- Use analytics, business intelligence, and AI-supported tools to identify trends, outliers, and recurring workflow concerns before external reviewers do.
- Provide ongoing role-based education that helps clinicians understand how documentation supports eligibility, medical necessity, reimbursement, compliance, and quality outcomes.
💬 Discussion Question
If Medicare's analytics reviewed every data point your organization generates today, would your documentation, assessments, claims, and quality data consistently tell one clear clinical story, and what processes are in place to identify gaps before an external reviewer does?
The Downdraft Is Getting Stronger: The Moratorium Was Only the Beginning
09/14/2026 • 9 Minute Read
Executive Summary
Several months after CMS implemented a nationwide Medicare enrollment moratorium affecting home health and hospice providers, additional signals are emerging that federal regulators are intensifying their focus on fraud prevention, program integrity, and provider oversight. Proposed legislation that would significantly increase Health Care Fraud and Abuse Control (HCFAC) funding through FY 2030, combined with CMS's own statements regarding investigations, site visits, advanced analytics, and accelerated removal of suspected fraudulent providers, suggests that organizations should prepare for a more rigorous enforcement environment. While legitimate providers are not the targets of fraud initiatives, history shows that increased enforcement creates greater scrutiny across the provider community. The strongest defense remains a well-documented, compliant, and data-driven operation supported by effective compliance and quality programs.
Federal fraud enforcement efforts continue expanding beyond enrollment restrictions.
CMS and enforcement agencies increasingly rely on analytics to identify outliers.
Accurate records remain the most effective protection during audits and reviews.
Organizations must identify issues before regulators identify them.
The Moratorium Was a Warning Signal, Not the Final Action
The most important message from the May 13, 2026 Medicare enrollment moratorium may not be the enrollment restrictions themselves, but what they revealed about federal priorities.
When CMS announced the nationwide enrollment moratorium for home health and hospice providers, many existing agencies may have concluded that the action primarily affected new entrants into Medicare. However, CMS clearly communicated that the moratorium would be accompanied by targeted investigations, advanced data analytics, enhanced site verification activities, and accelerated actions against providers suspected of fraud. Although the moratorium currently applies to initial enrollments and certain non-exempt changes in majority ownership, the broader takeaway is that home health and hospice remain areas of significant federal concern regarding fraud, waste, and abuse.
Another Signal: New Legislative Attention to Health Care Fraud
The proposed Protecting Taxpayers from Health Care Fraudsters Act represents another indicator that federal policymakers are maintaining a long-term focus on health care fraud enforcement. The legislation specifically references hospice, home health, and durable medical equipment suppliers and highlights concerns regarding sophisticated criminal enterprises targeting Medicare benefits.
The bill cites significant growth in hospice providers in Los Angeles County, references billions in hospice and home health payments, and points to concerns regarding overbilling and fraudulent activity. If enacted, the legislation would increase funding for HHS, DOJ, HHS OIG, the FBI, the Medicare Integrity Program, and the Medicare-Medicaid Data Match Program through FY 2030. Although House consideration has been postponed and the bill has not yet become law, the existence of the proposal reinforces a clear policy trend toward stronger oversight and enforcement.
What Increased Enforcement Means for Compliant Providers
Legitimate providers should not assume that stronger fraud enforcement efforts only affect bad actors. Historically, heightened enforcement environments result in increased scrutiny across the entire provider community. Documentation standards become more important, audits become more thorough, and regulators increasingly rely on data to identify providers whose utilization patterns differ from peers.
Organizations should ensure that eligibility is properly supported, physician orders and certifications are accurate, plans of care are individualized, services are medically necessary, and documentation clearly reflects what occurred during every patient encounter. Billing must consistently align with the clinical record. Most importantly, Compliance and QAPI programs should be capable of detecting concerns before outside reviewers do.
Why Internal Data Analytics Matter More Than Ever
Federal program integrity initiatives increasingly rely on advanced analytics to identify unusual provider behavior. As regulators leverage more sophisticated technology, providers should do the same. Organizations should routinely monitor utilization trends, long lengths of stay, live-discharge rates, referral concentrations, diagnosis patterns, clinician-specific utilization, and billing trends that may indicate compliance risk.
For Axxess organizations, this is where operational technology can play an important role. Leaders should leverage BI Dashboard reporting and real-time operational data to identify trends and outliers before they become larger compliance concerns. Axxess Intelligence can help organizations evaluate performance patterns and identify areas requiring additional review. Ask Axxess can further simplify access to insights that support proactive decision-making and compliance monitoring. PEPPER reports should also be incorporated into routine compliance reviews as an additional source of comparative billing analysis.
Connecting Compliance and QAPI to Operational Improvement
One chart correction rarely solves a systemic problem. Strong organizations use audit findings to identify root causes, educate staff, implement corrective actions, and measure results over time. This is where the connection between Compliance and QAPI becomes critical. A compliance finding should trigger a broader evaluation of processes, policies, and workflows to determine whether similar risks exist elsewhere in the organization.
Axxess solutions support this approach in several ways. Axxess Intelligence can automate compliance-focused billing reviews and identify opportunities for corrective action before claims are submitted. The OASIS Scrubber helps improve assessment accuracy and supports compliance prior to submission. In addition, Axxess Training and Certification offers QAPI training resources that can help organizations strengthen quality oversight, documentation practices, and continuous performance improvement efforts.
Ownership Changes Require Additional Attention
The current moratorium serves as a reminder that enrollment compliance extends beyond new agency creation. CMS has indicated that certain non-exempt changes in majority ownership may also be affected. Organizations considering ownership changes, acquisitions, restructuring activities, or strategic transactions should carefully evaluate enrollment implications before proceeding.
Leadership teams should routinely review organizational structures, ownership records, and CMS-855A information. Governance oversight matters. Ownership and enrollment compliance should be reviewed regularly and reflected in board-level discussions and documentation.
The Real Message: Watch the Downdraft
Whether the proposed legislation advances or not, the larger trend remains clear. CMS has already communicated its intention to intensify investigations, use advanced analytics, conduct site verification, and strengthen program integrity efforts. The enrollment moratorium may have been the first visible sign, but it is unlikely to be the last. Organizations that invest now in compliance infrastructure, documentation quality, analytics, governance oversight, and staff education will be substantially better positioned if the enforcement environment continues to intensify.
5 Recommendations for Home Health and Hospice Organizations
- Conduct regular third-party audits focused on eligibility, medical necessity, certifications, physician orders, plans of care, visit documentation, and claims accuracy.
- Implement routine reviews of utilization, billing, referral, and clinician performance data using BI Dashboard reporting, Axxess Intelligence, and PEPPER reports to identify potential outliers early.
- Strengthen the connection between Compliance and QAPI by requiring root-cause analysis, corrective action plans, staff education, and documented follow-up for every significant finding.
- Leverage Axxess tools such as OASIS Scrubber, Axxess Intelligence, Ask Axxess, and Axxess Training and Certification resources to improve compliance monitoring and operational readiness.
- Review ownership structures, CMS-855A information, and enrollment requirements at least quarterly and before any restructuring, acquisition, or ownership transaction.
💬 Discussion Question
If CMS were to expand enforcement efforts over the next 12 to 24 months, could your organization use its current documentation, analytics, compliance, and QAPI processes to confidently defend every claim, certification, and patient record reviewed by regulators?
CMS Is Tightening the Screws: The Enrollment Moratorium Is Temporary. The Compliance Message Is Not.
09/09/2026 • 8 Minute Read
Executive Summary
Many organizations are viewing CMS's nationwide enrollment moratorium for new home health agencies and hospices as a barrier affecting only new entrants. That interpretation misses the larger strategic signal. CMS is pairing the moratorium with enhanced investigations, advanced analytics, site-verification activities, and proposed enrollment reforms that could dramatically increase provider accountability. If finalized, new enrollment provisions would expand denial and revocation authorities while making revocations retroactive, potentially exposing organizations to repayment risk dating back to the onset of noncompliance. For executives and governing bodies, enrollment compliance is no longer simply an administrative responsibility. It is a board-level risk management issue that requires ongoing monitoring of ownership structures, disclosures, management changes, locations, licensure status, and Medicare enrollment accuracy.
CMS is using the moratorium as part of a broader program-integrity strategy.
Advanced analytics, investigations, and site verification efforts are accelerating.
Ownership, management, and disclosure accuracy are becoming major compliance priorities.
Boards should treat enrollment compliance as an enterprise risk issue.
Beyond the Moratorium: Understanding CMS's Broader Compliance Strategy
The most important question for leaders is not whether the enrollment moratorium will end, but how CMS's evolving oversight model will affect organizations that remain enrolled.
On May 13, 2026, CMS implemented a six-month nationwide Medicare enrollment moratorium covering new Home Health Agencies (HHAs), Hospices, and certain non-exempt changes in majority ownership. Applications subject to the moratorium are being denied, and CMS retains authority to extend the moratorium in additional six-month increments. While existing providers may continue billing Medicare, the broader regulatory landscape suggests that organizations should avoid viewing current operations as business as usual.
What Is Changing?
CMS has publicly connected the moratorium to efforts targeting fraud, waste, and abuse. More importantly, the agency is simultaneously increasing investigative activity through advanced data analytics, site-verification reviews, and accelerated actions against suspected noncompliant providers. The result is a compliance environment that is becoming more proactive, data-driven, and operationally focused.
In parallel, the CY 2027 Home Health Proposed Rule contains enrollment-related provisions that reach well beyond home health and hospice. Proposed changes include retroactive enrollment revocations, expanded denial and revocation authorities, and increased scrutiny of ownership structures, managing employees, licensure status, program participation history, and changes in organizational control.
Why It Matters
Historically, many providers focused compliance efforts on clinical quality, survey readiness, and reimbursement accuracy. CMS is signaling that organizational transparency and enrollment integrity now deserve equal attention. Regulators are increasingly evaluating whether provider records accurately reflect ownership, management, locations, disclosures, and operational realities.
If retroactive revocation proposals are finalized, organizations could face significantly greater financial exposure. Rather than simply losing billing privileges prospectively, providers could become vulnerable to repayment demands dating back to the point where CMS determines noncompliance began. This elevates enrollment maintenance from an administrative task to a core financial and governance concern.
The Governance Imperative
Executive leaders and governing bodies should recognize that Medicare enrollment compliance is not solely the responsibility of an enrollment specialist or administrator. Ownership changes, management transitions, branch activations, facility relocations, accreditation updates, and licensure modifications can all create enrollment obligations that must be reported accurately and within required timelines.
Organizations should implement structured reviews of PECOS records, Medicare disclosures, practice locations, branches, managing employees, governing body information, and organizational charts. Integrating these reviews into compliance and QAPI oversight creates accountability and helps identify discrepancies before regulators do.
A Key Date to Watch
The initial six-month moratorium period is scheduled to conclude in November 2026. CMS must determine whether to lift or extend the moratorium before that deadline, and any extension would be announced through the Federal Register. Organizations contemplating growth transactions, acquisitions, ownership restructuring, or market-entry strategies should closely monitor developments leading up to November 13, 2026.
Operational Readiness in a New Era of Oversight
Site verification activities remind providers that enrollment compliance extends into daily operations. Agencies should assess whether business locations are fully operational, signage is present and accurate, business hours are current, enrollment addresses match Medicare records, and staff are available to support verification activities. The ability to demonstrate operational legitimacy has become a critical component of compliance readiness.
5 Recommendations for Home Health and Hospice Organizations
- Conduct a comprehensive quarterly review of PECOS enrollment records and reconcile them against current ownership, leadership, locations, branches, and operational structures.
- Require Medicare enrollment impact assessments for every ownership, management, administrator, and organizational control change before implementation whenever possible.
- Perform internal site-verification audits that evaluate operational readiness, signage, staffing availability, business hours, and enrollment-record accuracy.
- Incorporate Medicare enrollment compliance into QAPI and compliance oversight programs, with regular reporting to executive leadership and governing bodies.
- Complete detailed Medicare enrollment due diligence before any acquisition, sale, merger, restructuring, or change in majority ownership transaction.
💬 Discussion Question
If CMS were to conduct a comprehensive enrollment review of your organization tomorrow, what governance, operational, or ownership-related vulnerabilities would leadership want identified and corrected today?
CMS Corrected the FY 2027 Hospice Rates. The Real Risk Is Acting on the Wrong Numbers.
09/03/2026 • 6 Minute Read
Executive Summary
Many hospice organizations have already completed budgeting, reimbursement forecasting, operational planning, and system preparations for FY 2027. CMS's announcement that a technical error affected the hospice wage index fundamentally changes that equation. Because the agency recalculated wage index values for all CBSAs and rural areas and updated national payment rates for every level of hospice care, organizations that continue relying on the originally published figures risk making financial, operational, and technology decisions based on outdated reimbursement assumptions. Executive leaders should treat this correction as an enterprise-wide validation exercise that spans finance, billing, operations, contracting, analytics, and vendor management before October 1 implementation.
CMS updated wage indexes and payment rates nationwide.
Previously downloaded data may no longer be accurate.
Billing and software platforms require verification.
Corrected rates take on heightened importance before implementation.
When a Technical Correction Creates Strategic Consequences
The issue is not the correction itself. The issue is how many organizational decisions may already be based on information that has changed.
CMS acknowledged a technical error affecting the FY 2027 hospice wage index and subsequently recalculated wage index values for all Core-Based Statistical Areas and rural areas. The revision also required updates to wage index standardization factors and national hospice payment rates across every level of care.
Why Leaders Should Pay Attention
Most organizations begin fiscal-year planning long before implementation dates arrive. Finance teams develop revenue forecasts, operational leaders establish budgets, consultants prepare reimbursement analyses, and vendors update software systems. When foundational payment assumptions change, even modest reimbursement differences can affect organizational forecasts when applied across an entire census.
Executive teams should view the correction as a governance issue rather than a simple reimbursement update. Organizations must know whether existing planning documents, board reports, analytics models, productivity assumptions, and technology configurations reflect the latest CMS guidance.
Where Organizations Face the Greatest Exposure
Several operational areas deserve immediate review:
- FY 2027 financial forecasts and budgeting assumptions
- Location-specific wage index calculations
- Rate sheets and payer planning models
- Billing and revenue cycle system configurations
- EMR and reimbursement software updates
- Leadership and board-level financial reporting
Importantly, organizations should verify all hospice payment categories rather than focusing solely on Routine Home Care. CMS indicated that the correction affects payment rates for every level of hospice care, making a comprehensive review essential.
A Single Source of Truth Matters More Than Ever
One of the most common challenges following regulatory corrections is version control. Different departments may rely on different spreadsheets, downloads, presentations, or vendor-generated analyses. When organizations operate from conflicting data sets, inconsistent decisions become inevitable.
Executive leaders should ensure that finance, operations, reimbursement, compliance, and technology teams validate their assumptions against the corrected CMS information and archive the materials used for decision making.
5 Recommendations for Hospice Organizations
- Validate the corrected CMS wage index for every CBSA and rural location where services are delivered.
- Recalculate FY 2027 revenue projections, budget assumptions, and reimbursement forecasts using updated information.
- Obtain formal confirmation from billing vendors, EMR partners, and reimbursement software providers that corrected rates have been implemented.
- Review payment impacts across Routine Home Care, Continuous Home Care, Inpatient Respite Care, and General Inpatient Care.
- Establish a centralized repository for corrected CMS materials and require all departments to utilize the same verified source.
💬 Discussion Question
How will your organization verify that every budget, reimbursement model, and technology system is aligned with the corrected FY 2027 hospice payment information before October 1?